Crackdown On Illegal Drugs And Unlicensed Pharmacies In Dimapur

Shillong:  In a bid to combat illegal drug sales and ensure compliance with health regulations, a team from the department of Health & Family Welfare (H&FW), Drug Control, initiated an intensive inspection of drug licenses and the sale of banned drugs in pharmacies across Dimapur. The drive will also cover Chümoukedima district.

Addressing the media at the District Hospital Dimapur (DHD), Health minister P Paiwang Konyak revealed that illegal drugs, banned by the Indian Council of Medical Research (ICMR), were being sold in some pharmacies. He warned that strict action would be taken against any pharmacy found selling such drugs.

The minister stated that the team would also verify the status of pharmacy licenses, ensuring they were properly renewed and that only qualified pharmacists were operating the establishments. He emphasized that any discrepancies would be addressed, and the ongoing checks would continue in the coming days.

Speaking to Nagaland Post, Deputy Drugs Controller Tiatoshi Amer, who also oversees licensing, explained that the state government had already initiated a crackdown on illegal drugs, in line with the ICMR’s ban on certain categories of medications.

He mentioned that some pharmacies had been found selling banned drugs and that these would be thoroughly inspected. If any such drugs were found, the pharmacy’s license would be revoked.

Additionally, the inspection would focus on pharmacies being run by unauthorized or unqualified individuals. Amer emphasized that the authorities had provided ample time for pharmacies to employ qualified pharmacists, and any failure to comply would result in serious consequences.

Pharmacies operating without valid licenses would be issued a show-cause notice, requiring them to renew their licenses. Failure to comply would lead to license cancellation.

Amer also disclosed that 49 licenses had already been suspended, and if any pharmacies were found to be operating with illegal or invalid documents, the team would recommend the cancellation of their licenses to the government.

Related Posts

  • Pharma
  • July 24, 2025
  • 137 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 230 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra